NEW YORK (GenomeWeb News) - Leiden University Medical Center said yesterday that it has acquired a FlexArrayer from FlexGen for in-house synthesis of oligonucleotide microarrays.
FlexGen is a LUMC spinoff company.
Johan den Dunnen, head of the Leiden Genome Technology Center, said in a statement that the center will use the FlexArrayer for “well established types of genetic analyses but [we] also intend to work on the development of new applications.”
Specifically, den Dunnen said, LGTC is “keen to implement” the system for array-based hybridization capture to sequence specific DNA regions.
Financial terms of the agreement were not provided.